Reynders McVeigh Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-113,480
| Closed | -$1.03M | – | 229 |
|
|
2022
Q1 | $1.03M | Sell |
113,480
-31,970
| -22% | -$291K | 0.06% | 103 |
|
|
2021
Q4 | $2.98M | Buy |
145,450
+14,720
| +11% | +$301K | 0.17% | 63 |
|
|
2021
Q3 | $3.34M | Buy |
130,730
+11,765
| +10% | +$301K | 0.2% | 64 |
|
|
2021
Q2 | $4.16M | Buy |
118,965
+14,780
| +14% | +$517K | 0.25% | 56 |
|
|
2021
Q1 | $3.47M | Buy |
104,185
+36,055
| +53% | +$1.2M | 0.23% | 62 |
|
|
2020
Q4 | $1.77M | Buy |
+68,130
| New | +$1.77M | 0.12% | 79 |
|